Skip to content

The effect of Melatonin and QT on complications during and after open heart surgery

Comparison of the effect of Melatonin and Q10 on clinical outcomes following coronary artery bypass surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130311012782N58
Enrollment
105
Registered
2024-02-16
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CAD. Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris

Interventions

Intervention 1: In this group, 20 mg of oral Melatonin(made by Razak institute) is given to the patients 24 hours before the operation and 20 mg 2 hours before the operation. Intervention 2: In this g

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Age range above 40 years Candidate for coronary artery bypass surgery Not taking psychoactive drugs Absence of contraindications for the administration of melatonin and Q10 (pregnancy or decision to become pregnant, breastfeeding • Seizure disorders, bleeding disorders, autoimmune diseases such as rheumatoid arthritis, lupus, MS, High blood pressure, organ transplant, liver problems, kidney problems) Patient consent to participate in this study. No drug addiction

Exclusion criteria

Exclusion criteria: Need for another surgery Pump time higher than 120 minutes Reoperation required due to bleeding Death of the patient before completing the study

Design outcomes

Primary

MeasureTime frame
Occurrence of arrhythmia. Timepoint: ?During and after the pump, the first to third day of hospitalization in the intensive care unit. Method of measurement: by electrocardiography.

Secondary

MeasureTime frame
Blood Urea Nitrogen(BUN). Timepoint: Before the operation and the first, second and third days of hospitalization in the intensive care unit. Method of measurement: Measurement of blood urea concentration by photometric method.;Blood creatinine level. Timepoint: Before the operation and the first, second and third days of hospitalization in the intensive care unit. Method of measurement: By Kinetic Jaffe method.;Blood pressure. Timepoint: Before the pump, during the pump, after the pump and the first to the third day of hospitalization in the intensive care unit. Method of measurement: By arterial catheter (arterial line).;Heart bit. Timepoint: Before the pump, after the pump and the first to the third day of hospitalization in the intensive care unit. Method of measurement: Pulse oximeter.;Restlessness and agitation. Timepoint: From the first to the third day of hospitalization in the intensive care unit. Method of measurement: By the Richmond scale.;Hospitalization time. Timepoint: From the time of admission to the discharge of the patient from the hospital. Method of measurement: By patient record.;Amount of Inotrope consumed. Timepoint: From the time of entering the operating room until the time of discharge from the intensive care unit. Method of measurement: Calculate the amount of inotrope consumed in milligrams.;Duration of mechanical ventilation. Timepoint: From the time of entering the operating room until the end of the endotracheal tube in the intensive care unit. Method of measurement: Calculation of the time interval from induction of anesthesia to removal of the endotracheal tube.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirreza Hemasian

Esfahan University of Medical Sciences

dr.amirhemasian@gmail.com+98 31 3669 2174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026